REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/24/2025
Back to search
Official data from USPTO
PISA FARMACEUTICA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
56
Latest update
03/25/2025
Trademark type
Combined
Nice classes
35, 40
Filing date
05/16/2016
Registration date
03/24/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/24/2020
Last transaction
03/25/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
11/06/2017
First use in commerce
11/06/2017
Drawing code
5
Owner type
03
Owner location
Guadalajara, MX
Examiner
MCBRIDE, THEODORE
Law office
L30
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of "PISA" in stylized wording. The "I" in "PISA" is lowercase and smaller than the other letters in "PISA".
Holders and representatives
Holders
Laboratorios Pisa, S.A. de C.V.
Representatives
Karri K. Bradley Schwabe, Williamson & Wyatt, P.C.
Technical classification
Nice Classes
Class 35Class 40
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Marketing services for pharmaceuticalsmedical equipmentantibiotics; retail store services featuring pharmaceuticalsmedical equipment
Class 40
Custom manufacture of pharmaceutical and nutritional compounds
Publications
History of USPTO decisions and trademark events.
56 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
03/24/2020
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/20/2020
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/19/2020
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/07/2020
IUAF
USE AMENDMENT FILED
01/16/2020
EISU
TEAS STATEMENT OF USE RECEIVED
01/16/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/23/2019
EX5G
SOU EXTENSION 5 GRANTED
07/22/2019
EXT5
SOU EXTENSION 5 FILED
07/17/2019
EEXT
SOU TEAS EXTENSION RECEIVED
07/17/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/20/2018
EX4G
SOU EXTENSION 4 GRANTED
12/18/2018
EXT4
SOU EXTENSION 4 FILED
12/18/2018
EEXT
SOU TEAS EXTENSION RECEIVED
12/18/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/29/2018
EX3G
SOU EXTENSION 3 GRANTED
09/28/2018
NREV
NOTICE OF REVIVAL - E-MAILED
09/21/2018
TPEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
09/20/2018
PETG
PETITION TO REVIVE-GRANTED
09/20/2018
PROA
TEAS PETITION TO REVIVE RECEIVED
09/20/2018
MAB6
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
09/17/2018
NOAC
CORRECTED NOA E-MAILED
09/15/2018
ABN6
ABANDONMENT - NO USE STATEMENT FILED
09/14/2018
DPCC
DIVISIONAL PROCESSING COMPLETE
09/14/2018
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/04/2018
EXT3
SOU EXTENSION 3 FILED
07/24/2018
DRRR
DIVISIONAL REQUEST RECEIVED
07/20/2018
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
07/20/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/26/2018
EX2G
SOU EXTENSION 2 GRANTED
01/24/2018
EXT2
SOU EXTENSION 2 FILED
01/24/2018
EEXT
SOU TEAS EXTENSION RECEIVED
01/24/2018
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/07/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/07/2017
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/26/2017
EX1G
SOU EXTENSION 1 GRANTED
07/24/2017
EXT1
SOU EXTENSION 1 FILED
07/24/2017
EEXT
SOU TEAS EXTENSION RECEIVED
07/24/2017
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/24/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/29/2016
PUBO
PUBLISHED FOR OPPOSITION
11/29/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/09/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/26/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/18/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
10/18/2016
ALIE
ASSIGNED TO LIE
10/18/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/18/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
10/18/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/18/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/01/2016
GNRT
NON-FINAL ACTION E-MAILED
09/01/2016
CNRT
NON-FINAL ACTION WRITTEN
09/01/2016
DOCK
ASSIGNED TO EXAMINER
08/31/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/19/2016
NWAP
NEW APPLICATION ENTERED
05/19/2016
Continuous trademark protection
Get notified about every new filing that threatens PISA FARMACEUTICA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.